A detailed history of Qsemble Capital Management, LP transactions in Glaukos Corp stock. As of the latest transaction made, Qsemble Capital Management, LP holds 4,522 shares of GKOS stock, worth $595,863. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,522
Previous 2,659 70.06%
Holding current value
$595,863
Previous $251 Million 113.46%
% of portfolio
0.1%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$89.48 - $118.35 $166,701 - $220,486
1,863 Added 70.06%
4,522 $535 Million
Q1 2024

May 07, 2024

BUY
$76.4 - $96.33 $203,147 - $256,141
2,659 New
2,659 $251 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.27B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Qsemble Capital Management, LP Portfolio

Follow Qsemble Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qsemble Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Qsemble Capital Management, LP with notifications on news.